IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This research is being done to determine if a short course of Chloroquine (five weeks)
before, during and after whole brain radiation therapy (WBRT) will improve the overall
survival of subjects being treated for brain metastases.